William Jarnagin, MD

Chief Attending
Division of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, United States

Presentation(s):

• Conversion Therapy to Transplant or Surgical Resection in Patients with Unresectable Hepatocellular Carcinoma Treated with Boosted Dose of Yttrium-90 Radiation Segmentectomy

  Wednesday, April 2, 2025
  10:57 AM – 11:06 AM CT